Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Lilly describes another SERM derived from raloxifene

Sep. 19, 1997

Mitsubishi comes up with a new conjugate of 17beta-estradiol and a bisphosphonate

Sep. 19, 1997

Potent and selective N-type calcium channel blockers for stroke

Sep. 18, 1997

New raloxifene analogue from Lilly is a potent SERM

Sep. 18, 1997

3-D database search at Schering-Plough leads to potent, selective FPT inhibitors

Sep. 18, 1997

New anthraquinone interacting with telomeric G-quadruplex DNA

Sep. 18, 1997

Anticonvulsant profile of two new GABA uptake inhibitors

Sep. 18, 1997

Searle evaluates novel target for antifungal agents

Sep. 17, 1997

Eisai discovers potent, optically active triazole antifungal

Sep. 16, 1997

New compounds for influenza targeting cap-dependent endonuclease

Sep. 16, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...